What makes a Stem Cell Therapy successful or not has to do directly with the quality of the cells processed in the lab and the delivery protocols.
At Rejuvenare Stem Cell Therapy, we have mastered safety and efficacy with our proprietary protocols.
None of the SCT (Stem Cell Therapy) offered by Rejuvenare Stem Cell Therapy are “EXPERIMENTAL” as we do them in a routine most efficient way following each time our proven protocols in Peru, a country where SCT is Legal and Regulated.
Meet Our Team
Rejuvenare's CEO Carlo Velarde is intimately invested with the entire scope of stem cell research and therapy. Inspired by the breakthrough results by our medical and scientific talent, formulated our first treatment facility in the Dominican Republic. Invited to brief the Dominican Republic bioethics commission on the current state of research and therapies around the world. Responsible for identifying and recruiting medical and scientific talent worldwide to organize our great cause to help humanity fighting life altering disease.
A marketing strategist. Mr. Velarde has vast experience in international markets. Holding various degrees, from business and marketing to US banking and finance, he has held manufacturing facilities in both and two continents. A visionary and natural born entrepreneur, Mr Velarde has produced a series of successful ventures around the world to include our state of the art processing lab and new treatment hospital in Lima, Peru. Fluent in various languages, currently holds patents on intellectual property. Mr. Velarde is dedicated to taking Rejuvenare’s high standards to the world.
Dr. Jorge Tuma MD Interventional Cardiologist is Co-Founder of Rejuvenare Stem Cell Therapy
In 2002, the breakthrough revolution started regarding the research, development, and implementation of Stem Cell Therapies. Novel, clinical applications were tested for the first time in the human heart after years of animal studies to assess safety and efficacy.
These ground-breaking therapeutic results in Singapore and Thailand, led by the genius of Dr. Yael Porat, PHD. (Rejuvenanre’s Scientific Advisor) discovery of processing and expanding markers of cells found in peripheral blood were conclusive, and ever since, countless of clinical and scientific publications have proven that a new horizon has been outlined for the future of medicine.
In parallel to this, at the same time in Lima, Peru Rejuvenare’s Medical Director, Dr. Jorge Tuma MD, is among those visionaries. He understood the regenerative power of Stem Cell Therapy, and the ability of these cells to assist damaged organs in repairing themselves when implanted directly with a pure concentration of cells obtained from the bone marrow. In collaboration of his team of scientists, Dr. Tuma was creating therapeutic protocols to identify and separate cell markers using the patient’s own bone marrow, this process also yields the markers needed to regenerate heart tissue.
Dr. Tuma MD is the pioneer developer of the retrograde procedure which uses autologous adult stem cell therapy to treat heart disease. His protocols broke the mold of cell implantation into a damaged heart while optimizing the use of the markers CD 33,34’s. This procedure obtains conclusive results and the therapeutic desired outcome without wasting precious cells. This technique is now widely used worldwide and taught in all academic institutions.
While others were busy trying to patent or claim Dr. Tuma’s work, he continues to apply his success to regenerate other organs using similar protocols. He aims to master regenerative medicine using Stem Cell Therapy to treat other vital organs with safety and conclusive efficacy. His work has proven effective and has been shared worldwide in numerous scientific, academic, medical publications, and has been presented by Dr. Tuma as a guest, keynote speaker at major congresses and events.
Dr. Tuma is a visiting professor at Columbia University in New York City. He has more than 25 years of experience in interventional procedures, i.e. cardiac catheter, angioplasty, and coronary stent placement in more than 17,000 patients and over 9,000 Stem Cell Therapy procedures.
Since May 2005 he has treated more than 9000 patients with regenerative medicine through stem cell implantation. He is among the pioneers in the development of new techniques that offer patients a better quality of life.
Dr. Tuma is involved with collaborative programs in Peru, Argentina, Ecuador, Germany, India, and the United States. The newest program involves treating heart failure patients with one day, out-patient Stem Cell Therapies.
He has been the Assistant Professor (Faculty) to Columbia University for the past seven years along with serving as an Advisory Board Member of the International Cellular Medicine Society.
Alejandro D. Mesples
Dr. Mesples is a gifted and very talented Interventional Cardiologist.
Our Diabetes treatment protocols are based on the research and development of his pioneering work and published results worldwide.
USA certified by the Educational Commission for Foreign Medical Graduates (ECFMG), Since 2005 Dr. Mesples has immersed himself in bioscience research and development to become a leading international expert on the use of autologous bone-marrow SCT (Stem Cell Therapy) for patients suffering from Diabetes Type-1, peripheral vasculopathy and its complications.
A well published lead researcher for international medical journals, Dr. Mesples’ pioneering work has been presented in numerous medical publications and showcased in conferences and in three meta-analysis for his work in treatment of Diabetes which involved over 1500 patients around the world.
Rejuvenare’s Scientific Advisor, is a specialist in the biotechnology industry, having worked as an innovator, scientist, advisor, and director for both industry leaders and pioneering start-ups. Dr. Porat served as CTO for TheraVitae, where she established the R&D and manufacturing departments and was responsible for the research, development and production of the company’s GMP-compliant adult stem cell-based products used for preclinical and clinical studies, as well as for routine treatment of patients.
Previously, Dr. Porat worked for the global R&D division of Teva Pharmaceutical Industries Ltd (Nasdaq: TEVA) as Manager of the Biological Methods Development department where she lead multidisciplinary research teams in development of biological methods supporting pharmaceutical products development. Prior to Teva, she worked for XTL Biopharmaceuticals Ltd (Nasdaq: XTLB) as a senior project manager and member of the project leaders forum in charge of the company’s strategic planning. Dr. Porat, an author of many scientific publications and patents, holds MA and PhD degrees in Immunology from the Sackler School of Medicine, Tel-Aviv University, Israel.
Rejuvenare’s Clinical Research Director / Worldwide Patient Coordinator is an advanced open heart surgery – cardiovascular RN and Age Management nurse practitioner in stem cell therapy, and comes to Rejuvenare with a unique set of talents unmatched anywhere else. Paulene has had years of experience, both as Head Nurse for the Dr. Michael DeBakey team (pioneer in heart transplants), and was the RN and COO of an exclusive off shore stem cell research hospital. She has been sharply focused on wellness and anti aging therapies for decades and continues to apply her knowledge and skills to helping people stay well and youthful.
She holds licenses as a Registered Nurse, Certified Cardiovascular Nurse Specialist, ACLS Certified, (advanced cardiac life support) Certified Health Educator Hippocrates Health Institute.
• OR, ER and ICU experienced
• Anti-Aging and Wellness Consultant
• Bi-lingual in English and Spanish
• Trained under the world famous cardiovascular surgeon Dr. Michael DeBakey and was on the DeBakey team for three years.
Paulene has been sought after by all the major companies in the stem cell industry and chose Rejuvenare for its integrity-based model.
Trained in Rejuvenare’s proprietary stem cell protocols, Paulene is that very special patient advocate who will ensure a very smooth experience from beginning to follow up.
Rejuvenare’s Director of Regenerative Advanced Stem Cell Technology is an expert in Cellular Technology and Therapy. Professor Alvarez has over 25 years of experience in the medical field since earning his degree in Medical Technology from the University National Federico Villarreal, School of Medicine in Lima, Peru. He is licensed in Medical Technology, specializing in clinical lab work and pathological anatomy with a Masters in Medical Lab and Public Health.
Professor Marco Alvarez is a true pioneer in research and development of the processing and minimal manipulation of the bone marrow since 2002 and was among one of the first people to identify how to treat life altering diseases efficaciously and safely. His work in collaboration with Rejuvenare’s scientific advisory board and medical team has developed proprietary protocols that have conclusively proven to help our patients reclaim their quality of life.
Our proprietary cell processing protocols are the result of 15+ years of due diligence and consistent readjustments that have helped over 4,000 patients suffering from heart disease, PAD, Parkinson’s Disease, early dementia, stroke, COPD, and Pulmonary Fibrosis. These autologous personalized cells are unique to every patient and are custom processed to meet therapeutic expectations of each disease.
"Before this, I had exhausted every usual solution for a failing heart, including a pacemaker. I continued to worsen. My wife was determined to help me live. She discovered stem cell treatments and researched companies with successful results.
This led us to Rejuvenare.
In 2010, I received my stem cell treatment from Dr. Tuma in Peru. I experienced relief, a surge of energy and was soon back on the golf course"
- TOM POWELL
"In 2003, Scott was diagnosed with cardiomyopathy. His health deteriorated over the next 8 years to the point his cardiologist gave him little hope. Dying was not an option for Scott. He began researching stem cell therapy and how it was helping folks who had his disease. Through his research he contacted Rejuvenare, and through testing we determined he was a candidate for stem cell therapy. In his own words:
“Finally somebody was giving me hope rather than a death sentence.”
Scott received his treatment at our facilities in Peru and within a very short time was beginning to feel like his old self."
- SCOTT BURGESS
"I am 74 years old, in 2008 I was diagnosed with Parkinson’s Disease and my condition worsened steadily. My 2009 my symptoms were so bad I stopped going out in public. Tremors and concontrolled movements and jerks were embarrassing. I couldn’t remember things well. I couldn’t keep u pwith simple everyday tasks. I was increasingly frightened and uncertain about life. In 2010 a stroke left me paralyzed with little movement except for my head. My mind continued to work but my body would not respond. I was imprisoned, unable to move except talk and blink.
I was without hope.
My son Carlo is the CEO of Rejuvenare, advanced stem cell therapy. he knew stem cell therapy can often help stroke victims and had my case evaluated by their medical director immediately. My body responded quickly and positively to this nearly painless procedure – and with physical therapy – I quickly regained movement and mental clarity."
- SYBIL GEARN
If you would like to request information on treatment, please click the button below to fill out a quick questionnaire. You’ll be paired with a specialist, knowledgeable in all aspects of our therapies, and you’ll be contacted to discuss your needs shortly.Contact Us